[1]
|
Pilania, R.K., Tremoulet, A.H., Prinja, S., Dahdah, N. and Singh, S. (2025) Kawasaki Disease: The Most Common Cause of Acquired Heart Disease among Children Globally. Cardiology in the Young, 35, 441-443. https://doi.org/10.1017/s1047951125000459
|
[2]
|
Conti, G., Giannitto, N., De Luca, F.L., et al. (2020) Kawasaki Disease and Cardiac Involvement: An Update on the State of the Art. Journal of Biological Regulators and Homeostatic Agents, 34, 47-53.
|
[3]
|
Zhang, D., Liu, L., Huang, X. and Tian, J. (2020) Insights into Coronary Artery Lesions in Kawasaki Disease. Frontiers in Pediatrics, 8, Article 493. https://doi.org/10.3389/fped.2020.00493
|
[4]
|
Soni, P.R., Noval Rivas, M. and Arditi, M. (2020) A Comprehensive Update on Kawasaki Disease Vasculitis and Myocarditis. Current Rheumatology Reports, 22, Article No. 6. https://doi.org/10.1007/s11926-020-0882-1
|
[5]
|
McCrindle, B.W., Rowley, A.H., Newburger, J.W., et al. (2017) Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals from the American Heart Association. Circulation, 135, e927-e999.
|
[6]
|
Barman, P., Pilania, R.K., Cv, G., Thangaraj, A., Arora, M. and Singh, S. (2024) Treatment Intensification in Kawasaki Disease—Current Perspectives. Expert Review of Clinical Immunology, 20, 1179-1191. https://doi.org/10.1080/1744666x.2024.2378900
|
[7]
|
Saguil, A., Fargo, M. and Grogan, S. (2015) Diagnosis and Management of Kawasaki Disease. American Family Physician, 91, 365-371.
|
[8]
|
Stemberger Maric, L., Papic, N., Sestan, M., Knezovic, I. and Tesovic, G. (2018) Challenges in Early Diagnosis of Kawasaki Disease in the Pediatric Emergency Department: Differentiation from Adenoviral and Invasive Pneumococcal Disease. Wiener Klinische Wochenschrift, 130, 264-272. https://doi.org/10.1007/s00508-018-1324-1
|
[9]
|
Chen, Y., Lin, T., Wang, C., Liang, W., Lian, G., Zanin, M., et al. (2022) Human Adenovirus (HAdV) Infection in Children with Acute Respiratory Tract Infections in Guangzhou, China, 2010-2021: A Molecular Epidemiology Study. World Journal of Pediatrics, 18, 545-552. https://doi.org/10.1007/s12519-022-00590-w
|
[10]
|
Zhou, H., Chen, D., Ru, X., Shao, Q., Chen, S., Liu, R., et al. (2024) Epidemiological and Clinical Characteristics of Adenovirus-Associated Respiratory Tract Infection in Children in Hangzhou, China, 2019-2024. Journal of Medical Virology, 96, e29957. https://doi.org/10.1002/jmv.29957
|
[11]
|
Liu, M., Xu, Q., Li, T., Wang, T., Jiang, B., Lv, C., et al. (2023) Prevalence of Human Infection with Respiratory Adenovirus in China: A Systematic Review and Meta-Analysis. PLOS Neglected Tropical Diseases, 17, e0011151. https://doi.org/10.1371/journal.pntd.0011151
|
[12]
|
Mao, N., Zhu, Z., Zhang, Y. and Xu, W. (2022) Current Status of Human Adenovirus Infection in China. World Journal of Pediatrics, 18, 533-537. https://doi.org/10.1007/s12519-022-00568-8
|
[13]
|
Ho, S., Zhou, Y., Ho, S., Hu, Y., Yen, T., Huang, K.A., et al. (2025) Clinical Characteristics and Severity Predictors of Pediatric Adenovirus Infections. Journal of Medical Virology, 97, e70248. https://doi.org/10.1002/jmv.70248
|
[14]
|
Liang, Y., Wei, J., Shen, J., Liang, Z., Ma, X., Du, Y., et al. (2025) Immunological Pathogenesis and Treatment Progress of Adenovirus Pneumonia in Children. Italian Journal of Pediatrics, 51, Article No. 4. https://doi.org/10.1186/s13052-024-01836-1
|
[15]
|
Dotan, M., Zion, E., Ben-Zvi, H., et al. (2021) Adenovirus Infection in Children with Down Syndrome. The Israel Medical Association Journal, 23, 416-419.
|
[16]
|
Huang, S., Chen, C., Weng, K., Chien, K., Hung, Y., Hsieh, K., et al. (2020) Adenovirus Infection and Subsequent Risk of Kawasaki Disease: A Population-Based Cohort Study. Journal of the Chinese Medical Association, 83, 302-306. https://doi.org/10.1097/jcma.0000000000000266
|
[17]
|
庞晓燕, 冀云鹏, 周雪原, 等. 2020-2021年呼和浩特市儿童呼吸道腺病毒感染的流行病学和实验室检测及临床特征研究[J]. 现代检验医学杂志, 2023, 38(2): 129-135.
|
[18]
|
Huang, H., Jiang, J., Shi, X., Qin, J., Dong, J., Xu, L., et al. (2022) Nomogram to Predict Risk of Resistance to Intravenous Immunoglobulin in Children Hospitalized with Kawasaki Disease in Eastern China. Annals of Medicine, 54, 442-453. https://doi.org/10.1080/07853890.2022.2031273
|
[19]
|
Kang, J., Jung, J., Kim, Y., Huh, K., Hong, J., Kim, D.W., et al. (2022) Temporal Correlation between Kawasaki Disease and Infectious Diseases in South Korea. JAMA Network Open, 5, e2147363. https://doi.org/10.1001/jamanetworkopen.2021.47363
|
[20]
|
Valtuille, Z., Lefevre-Utile, A., Ouldali, N., Beyler, C., Boizeau, P., Dumaine, C., et al. (2023) Calculating the Fraction of Kawasaki Disease Potentially Attributable to Seasonal Pathogens: A Time Series Analysis. E Clinical Medicine, 61, Article 102078. https://doi.org/10.1016/j.eclinm.2023.102078
|
[21]
|
Kang, J., Kim, Y., Huh, K., Hong, J., Kim, D.W., Kim, M.Y., et al. (2021) Reduction in Kawasaki Disease after Nonpharmaceutical Interventions in the COVID-19 Era: A Nationwide Observational Study in Korea. Circulation, 143, 2508-2510. https://doi.org/10.1161/circulationaha.121.054785
|
[22]
|
Bitsadze, V.O., Grigoreva, K., Khizroeva, J.K., Pervunina, T.M., Tsibizova, V.I., Tretyakova, M.V., et al. (2020) Novel Coronavirus Infection and Kawasaki Disease. The Journal of Maternal-Fetal & Neonatal Medicine, 35, 3044-3048. https://doi.org/10.1080/14767058.2020.1800633
|
[23]
|
马忠正, 石和丝, 康伟莉, 等. 流感病毒感染与川崎病发病的关系及患儿外周血细胞因子和T淋巴细胞水平变化[J]. 中华医院感染学杂志, 2024, 34(7): 1100-1104.
|
[24]
|
Sankannaavr, A., Puttalinga, D. and Bagalkot, P.S. (2024) Subsequent Development of Kawasaki Disease Following Acute Human Adenovirus Infection among Siblings. BMJ Case Reports, 17, e257257. https://doi.org/10.1136/bcr-2023-257257
|
[25]
|
Turnier, J.L., Anderson, M.S., Heizer, H.R., Jone, P., Glodé, M.P. and Dominguez, S.R. (2015) Concurrent Respiratory Viruses and Kawasaki Disease. Pediatrics, 136, e609-e614. https://doi.org/10.1542/peds.2015-0950
|
[26]
|
Chang, L., Lu, C., Shao, P., Lee, P., Lin, M., Fan, T., et al. (2014) Viral Infections Associated with Kawasaki Disease. Journal of the Formosan Medical Association, 113, 148-154. https://doi.org/10.1016/j.jfma.2013.12.008
|
[27]
|
Duignan, S., Doyle, S.L. and McMahon, C.J. (2019) Refractory Kawasaki Disease: Diagnostic and Management Challenges. Pediatric Health, Medicine and Therapeutics, 10, 131-139. https://doi.org/10.2147/phmt.s165935
|
[28]
|
Moracas, C., Poeta, M., Grieco, F., et al. (2024) Bacterial-Like Inflammatory Response in Children with Adenovirus Leads to Inappropriate Antibiotic Use: A Multicenter Cohort Study. Infection, 2024, 1-12.
|
[29]
|
Cai, W. and Ding, S. (2022) Retrospective Analysis of Clinical Characteristics and Related Influencing Factors of Kawasaki Disease. Medicine, 101, e32430. https://doi.org/10.1097/md.0000000000032430
|
[30]
|
Hameed, A., Alshara, H. and Schleussinger, T. (2017) Ptosis as a Complication of Kawasaki Disease. BMJ Case Reports, 2017, bcr-2017-219687. https://doi.org/10.1136/bcr-2017-219687
|
[31]
|
Montenegro-Villalobos, J., Miranda-Jiménez, B., Ávila-Aguero, M.L. and Ulloa-Gutierrez, R. (2020) Subconjunctival Acute Bilateral Hemorrhages Due to Kawasaki Disease in a Costa Rican Girl: An Unusual Clinical Manifestation of the Disease. Cureus, 12, e10212. https://doi.org/10.7759/cureus.10212
|
[32]
|
Zhu, F. and Ang, J.Y. (2021) 2021 Update on the Clinical Management and Diagnosis of Kawasaki Disease. Current Infectious Disease Reports, 23, 1-11. https://doi.org/10.1007/s11908-021-00746-1
|
[33]
|
Santacruz Valdés, C., Ponce-Rosas, E. and Jimenez-Martinez, M. (2025) Proinflammatory Tear Cytokines in Human Adenoviral Keratoconjunctivitis and Clinical Eye Severity. Clinical Ophthalmology, 19, 439-448. https://doi.org/10.2147/opth.s497111
|
[34]
|
Bhakta, A., Thosani, P., Surendran, S., Kunchala, A. and Thergaonkar, R.W. (2024) Clinical and Laboratory Findings of Children Affected with Adenovirus Infection. Indian Journal of Pediatrics, 91, 1210-1210. https://doi.org/10.1007/s12098-024-05150-w
|
[35]
|
Imparato, R., Rosa, N. and De Bernardo, M. (2022) Antiviral Drugs in Adenovirus-Induced Keratoconjunctivitis. Microorganisms, 10, Article 2014. https://doi.org/10.3390/microorganisms10102014
|
[36]
|
Winters, S., Frazier, W. and Winters, J. (2024) Conjunctivitis: Diagnosis and Management. American Family Physician, 110, 134-144.
|
[37]
|
Jaggi, P., Kajon, A.E., Mejias, A., Ramilo, O. and Leber, A. (2012) Human Adenovirus Infection in Kawasaki Disease: A Confounding Bystander? Clinical Infectious Diseases, 56, 58-64. https://doi.org/10.1093/cid/cis807
|
[38]
|
Song, E., Kajon, A.E., Wang, H., Salamon, D., Texter, K., Ramilo, O., et al. (2016) Clinical and Virologic Characteristics May Aid Distinction of Acute Adenovirus Disease from Kawasaki Disease with Incidental Adenovirus Detection. The Journal of Pediatrics, 170, 325-330. https://doi.org/10.1016/j.jpeds.2015.11.021
|
[39]
|
Day-Lewis, M., Son, M.B.F. and Lo, M.S. (2024) Kawasaki Disease: Contemporary Perspectives. The Lancet Child & Adolescent Health, 8, 781-792. https://doi.org/10.1016/s2352-4642(24)00169-x
|
[40]
|
Nakayama, S., Kambe, N., Irie, H., Izawa, K., Nishijima, R., Ueno, H., et al. (2024) Psoriasiform Dermatitis Following Kawasaki Disease: A Case Report and Literature Review. https://doi.org/10.1111/pde.15859
|
[41]
|
Isidori, C., Sebastiani, L., Cardellini, M., Di Cara, G., Rigante, D. and Esposito, S. (2017) Early Desquamating Perineal Erythema in a Febrile Infant: A Characteristic Clinical Feature of Kawasaki Disease. International Journal of Environmental Research and Public Health, 14, Article 710. https://doi.org/10.3390/ijerph14070710
|
[42]
|
Loh, A., Kua, P. and Tan, Z. (2019) Erythema and Induration of the Bacillus Calmette-Guérin Site for Diagnosing Kawasaki Disease. Singapore Medical Journal, 60, 89-93. https://doi.org/10.11622/smedj.2018084
|
[43]
|
Tseng, H., Ho, J., Guo, M.M., Lo, M., Hsieh, K., Tsai, W., et al. (2016) Bull’s Eye Dermatoscopy Pattern at Bacillus Calmette-Guérin Inoculation Site Correlates with Systemic Involvements in Patients with Kawasaki Disease. The Journal of Dermatology, 43, 1044-1050. https://doi.org/10.1111/1346-8138.13315
|
[44]
|
Zhu, F.H. and Ang, J.Y. (2016) The Clinical Diagnosis and Management of Kawasaki Disease: A Review and Update. Current Infectious Disease Reports, 18, Article No. 32. https://doi.org/10.1007/s11908-016-0538-5
|
[45]
|
Niedermeier, A., Pfützner, W., Ruzicka, T., Thomas, P. and Happle, R. (2014) Superimposed Lateralized Exanthem of Childhood: Report of a Case Related to Adenovirus Infection. Clinical and Experimental Dermatology, 39, 351-353. https://doi.org/10.1111/ced.12311
|
[46]
|
Tanaka, A., Inoue, M., Hoshina, T. and Koga, H. (2021) Correlation of Coronary Artery Abnormalities with Fever Pattern in Patients with Kawasaki Disease. The Journal of Pediatrics, 236, 95-100. https://doi.org/10.1016/j.jpeds.2021.05.020
|
[47]
|
Peng, Y., Liu, X., Duan, Z., Cai, S., Duan, J. and Zhou, Y. (2021) Age-Related Differences in Clinical Characteristics of Kawasaki Disease. Brazilian Journal of Medical and Biological Research, 54, e10281. https://doi.org/10.1590/1414-431x202010281
|
[48]
|
Muto, T., Masuda, Y., Numoto, S., Kodama, S., Yamakawa, K., Takasu, M., et al. (2019) White Blood Cell and Neutrophil Counts and Response to Intravenous Immunoglobulin in Kawasaki Disease. Global Pediatric Health, 6, Article 2333794X19884826. https://doi.org/10.1177/2333794x19884826
|
[49]
|
Hu, J., Qian, W., Yu, Z., Xu, T., Ju, L., Hua, Q., et al. (2020) Increased Neutrophil Respiratory Burst Predicts the Risk of Coronary Artery Lesion in Kawasaki Disease. Frontiers in Pediatrics, 8, Article 391. https://doi.org/10.3389/fped.2020.00391
|
[50]
|
Zhang, R., Wang, H., Tian, S. and Deng, J. (2021) Adenovirus Viremia May Predict Adenovirus Pneumonia Severity in Immunocompetent Children. BMC Infectious Diseases, 21, Article No. 213. https://doi.org/10.1186/s12879-021-05903-4
|
[51]
|
Wu, P., Zeng, S., Yin, G., Huang, J., Xie, Z., Lu, G., et al. (2020) Clinical Manifestations and Risk Factors of Adenovirus Respiratory Infection in Hospitalized Children in Guangzhou, China during the 2011-2014 Period. Medicine, 99, e18584. https://doi.org/10.1097/md.0000000000018584
|
[52]
|
Tsai, C., Yu, H., Tang, K., Huang, Y. and Kuo, H. (2020) C-Reactive Protein to Albumin Ratio for Predicting Coronary Artery Lesions and Intravenous Immunoglobulin Resistance in Kawasaki Disease. Frontiers in Pediatrics, 8, Article 607631. https://doi.org/10.3389/fped.2020.607631
|
[53]
|
Gómez de Oña, C., Alvarez-Argüelles, M.E., Rojo-Alba, S., Casares, H., Arroyo, M., Rodríguez, J., et al. (2021) Alterations in Biochemical Markers in Adenovirus Infection. Translational Pediatrics, 10, 1248-1258. https://doi.org/10.21037/tp-20-333
|
[54]
|
Wang, Y., Sun, D. and Hu, H. (2024) Urinary Exosomal MicroRNA-200 Family: Diagnostic Biomarkers for Kawasaki Disease and Their Link to Inflammatory Markers. Cardiology in the Young, 35, 324-331. https://doi.org/10.1017/s1047951124036230
|
[55]
|
Chidambaram, A.C., Ramamoorthy, J.G. and Anantharaj, A. (2023) Neutrophil-Lymphocyte Ratio for Predicting Coronary Artery Lesions in Children with Kawasaki Disease. Indian Pediatrics, 60, 207-211. https://doi.org/10.1007/s13312-023-2836-1
|
[56]
|
Sun, J., Xiao, Y., Zhang, M., Ao, T., Lang, S. and Wang, J. (2018) Serum Inflammatory Markers in Patients with Adenovirus Respiratory Infection. Medical Science Monitor, 24, 3848-3855. https://doi.org/10.12659/msm.910692
|
[57]
|
Niu, M.M., Jiang, Q., Ruan, J.W., Liu, H.H., Chen, W.X., Qiu, Z., et al. (2021) Clinical Implications of Procalcitonin in Kawasaki Disease: A Useful Candidate for Differentiating from Sepsis and Evaluating IVIG Responsiveness. Clinical and Experimental Medicine, 21, 633-643. https://doi.org/10.1007/s10238-021-00709-9
|
[58]
|
Zeng, L., Wang, C., Song, Z., Liu, Q., Chen, D. and Yu, X. (2023) Prokineticin 2 as a Potential Biomarker for the Diagnosis of Kawasaki Disease. Clinical and Experimental Medicine, 23, 3443-3451. https://doi.org/10.1007/s10238-023-01078-1
|
[59]
|
Kim, S.H., Song, E.S., Yoon, S., Eom, G.H., Kang, G. and Cho, Y.K. (2021) Serum Ferritin as a Diagnostic Biomarker for Kawasaki Disease. Annals of Laboratory Medicine, 41, 318-322. https://doi.org/10.3343/alm.2021.41.3.318
|
[60]
|
Popper, S.J., Watson, V.E., Shimizu, C., Kanegaye, J.T., Burns, J.C. and Relman, D.A. (2009) Gene Transcript Abundance Profiles Distinguish Kawasaki Disease from Adenovirus Infection. The Journal of Infectious Diseases, 200, 657-666. https://doi.org/10.1086/603538
|
[61]
|
Park, J.H. and Choi, H.J. (2021) Clinical Implications of Thrombocytosis in Acute Phase Kawasaki Disease. European Journal of Pediatrics, 180, 1841-1846. https://doi.org/10.1007/s00431-021-03966-8
|
[62]
|
Arora, K., Guleria, S., Jindal, A.K., Rawat, A. and Singh, S. (2020) Platelets in Kawasaki Disease: Is This Only a Numbers Game or Something beyond? Genes & Diseases, 7, 62-66. https://doi.org/10.1016/j.gendis.2019.09.003
|
[63]
|
Bratincsak, A., Reddy, V.D., Purohit, P.J., Tremoulet, A.H., Molkara, D.P., Frazer, J.R., et al. (2012) Coronary Artery Dilation in Acute Kawasaki Disease and Acute Illnesses Associated with Fever. Pediatric Infectious Disease Journal, 31, 924-926. https://doi.org/10.1097/inf.0b013e31826252b3
|
[64]
|
Eichholz, K., Bru, T., Tran, T.T.P., Fernandes, P., Welles, H., Mennechet, F.J.D., et al. (2016) Immune-Complexed Adenovirus Induce Aim2-Mediated Pyroptosis in Human Dendritic Cells. PLOS Pathogens, 12, e1005871. https://doi.org/10.1371/journal.ppat.1005871
|
[65]
|
Lam, J.Y., Shimizu, C., Tremoulet, A.H., et al. (2022) A Machine-Learning Algorithm for Diagnosis of Multisystem Inflammatory Syndrome in Children and Kawasaki Disease in the USA: A Retrospective Model Development and Validation Study. The Lancet Digital Health, 4, e717-e726.
|
[66]
|
Hicar, M.D. (2020) Antibodies and Immunity During Kawasaki Disease. Frontiers in Cardiovascular Medicine, 7, Article 94. https://doi.org/10.3389/fcvm.2020.00094
|
[67]
|
Chen, Y., Wang, W., Chen, Y., Tang, Q., Zhu, W., Li, D., et al. (2019) MicroRNA-19a-3p Promotes Rheumatoid Arthritis Fibroblast-Like Synoviocytes via Targeting Socs3. Journal of Cellular Biochemistry, 120, 11624-11632. https://doi.org/10.1002/jcb.28442
|
[68]
|
Zhang, W., Wang, Y., Zeng, Y., Hu, L. and Zou, G. (2017) Serum miR-200c and miR-371-5p as the Useful Diagnostic Biomarkers and Therapeutic Targets in Kawasaki Disease. BioMed Research International, 2017, 1-8. https://doi.org/10.1155/2017/8257862
|
[69]
|
Ohashi, R., Fukazawa, R., Shimizu, A., Ogawa, S., Ochi, M., Nitta, T., et al. (2019) M1 Macrophage Is the Predominant Phenotype in Coronary Artery Lesions Following Kawasaki Disease. Vascular Medicine, 24, 484-492. https://doi.org/10.1177/1358863x19878495
|
[70]
|
Roe, K. (2020) High COVID-19 Virus Replication Rates, the Creation of Antigen-Antibody Immune Complexes and Indirect Haemagglutination Resulting in Thrombosis. Transboundary and Emerging Diseases, 67, 1418-1421. https://doi.org/10.1111/tbed.13634
|